Cranmer LD - Search Results

1

In-transit metastasis from melanoma presenting as lymphangiectasis: a case report.

Shekhel T, Glick RM, Cranmer LD. Shekhel T, et al. Among authors: cranmer ld. Cutis. 2009 Sep;84(3):151-8. Cutis. 2009. PMID: 19842575

2

Melanoma's radioresistant reputation challenged.

Cranmer LD. Cranmer LD. Oncology (Williston Park). 2010 Jun;24(7):656. Oncology (Williston Park). 2010. PMID: 20669804 No abstract available.

3

Rodent models of brain metastasis in melanoma.

Cranmer LD, Trevor KT, Bandlamuri S, Hersh EM. Cranmer LD, et al. Melanoma Res. 2005 Oct;15(5):325-56. doi: 10.1097/00008390-200510000-00002. Melanoma Res. 2005. PMID: 16179861 Review.

4

Erythematous annular plaques on the trunk.

LaPresto L, Cranmer L, Erickson CP, Morrison L, Curiel-Lewandrowski C. LaPresto L, et al. Arch Dermatol. 2012 Apr;148(4):531-6. doi: 10.1001/archderm.148.4.531-b. Arch Dermatol. 2012. PMID: 22508881 No abstract available.

5

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases.

Glazer ES, Bartels PH, Lian F, Kha ST, Morgan SS, da Silva VD, Yozwiak ML, Bartels HG, Cranmer LD, de Oliveira JK, Alberts DS, Warneke JA, Krouse RS. Glazer ES, et al. Among authors: cranmer ld. Melanoma Res. 2016 Jun;26(3):261-6. doi: 10.1097/CMR.0000000000000236. Melanoma Res. 2016. PMID: 26795273

6

Melanoma high-risk families' perceived health care provider risk communication.

Loescher LJ, Crist JD, Cranmer L, Curiel-Lewandrowski C, Warneke JA. Loescher LJ, et al. J Cancer Educ. 2009;24(4):301-7. doi: 10.1080/08858190902997290. J Cancer Educ. 2009. PMID: 19838889 Free PMC article.

7

A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.

LaPresto L, Cranmer L, Morrison L, Erickson CP, Curiel-Lewandrowski C. LaPresto L, et al. JAMA Dermatol. 2013 Mar;149(3):279-81. doi: 10.1001/jamadermatol.2013.2583. JAMA Dermatol. 2013. PMID: 23552479 Free PMC article. No abstract available.

8

A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.

Ebbinghaus S, Rubin E, Hersh E, Cranmer LD, Bonate PL, Fram RJ, Jekunen A, Weitman S, Hammond LA. Ebbinghaus S, et al. Among authors: cranmer ld. Clin Cancer Res. 2005 Nov 1;11(21):7807-16. doi: 10.1158/1078-0432.CCR-05-0909. Clin Cancer Res. 2005. PMID: 16278403 Clinical Trial.

9

Treatment of unresectable and metastatic cutaneous squamous cell carcinoma.

Cranmer LD, Engelhardt C, Morgan SS. Cranmer LD, et al. Oncologist. 2010;15(12):1320-8. doi: 10.1634/theoncologist.2009-0210. Epub 2010 Dec 8. Oncologist. 2010. PMID: 21147868 Free PMC article.

10

Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: improving on the current standard.

Gottlieb RH, Krupinski E, Chalasani P, Cranmer L. Gottlieb RH, et al. J Digit Imaging. 2012 Apr;25(2):258-65. doi: 10.1007/s10278-011-9407-9. J Digit Imaging. 2012. PMID: 21785917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page